Literature DB >> 7789988

Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2).

A Nakagawara1, X G Liu, N Ikegaki, P S White, D J Yamashiro, L M Nycum, J A Biegel, G M Brodeur.   

Abstract

There is increasing evidence that neutrophins and their receptors play an important role in regulating development of both the central and the peripheral nervous systems. Human TRK-A (NTRK1) and TRK-C (NTRK3) have been cloned and sequenced, but only a truncated form of human TRK-B has been published. Therefore, we isolated complementary DNAs spanning the entire coding region of both human full-length and truncated forms of TRK-B from human brain cDNA libraries. Human full-length TRK-B codes for a protein of 822 amino acid residues. The putative mature peptide sequence is 49% homologous to human TRK-A and 55% to full-length human TRK-C, with 40% amino acid identify among TRK-A, -B, and -C. Nine of 13 cysteine residues, 4 of 12N-glycosylation sites in the extracellular domain, and 10 of 13 tyrosine residues in the intracellular domain are conserved among human TRK-A, -B, and -C. There is a cluster of 10 serine residues in the juxtamembrane region of TRK-B that is absent in TRK-A. Two major sizes of TRK-B transcripts were expressed in human brain. Northern blot analysis using probes specific for the extracellular or the tyrosine kinase domain revealed that the 9.5-kb band encodes the full-length TRK-B mRNA and the 8.0-kb band encodes the truncated form of TRK-B mRNA. By fluorescence in situ hybridization and somatic cell hybrid mapping, the human TRK-B gene was localized to chromosome 9q22.1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789988     DOI: 10.1016/0888-7543(95)80055-q

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  25 in total

1.  A network map of BDNF/TRKB and BDNF/p75NTR signaling system.

Authors:  Varot K Sandhya; Rajesh Raju; Renu Verma; Jayshree Advani; Rakesh Sharma; Aneesha Radhakrishnan; Vishalakshi Nanjappa; Jayasuryan Narayana; B L Somani; Kanchan K Mukherjee; Akhilesh Pandey; Rita Christopher; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2013-04-20       Impact factor: 5.782

2.  Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor.

Authors:  S Mardy; Y Miura; F Endo; I Matsuda; L Sztriha; P Frossard; A Moosa; E A Ismail; A Macaya; G Andria; E Toscano; W Gibson; G E Graham; Y Indo
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

3.  Anti-tumor activity of phenoxybenzamine hydrochloride on malignant glioma cells.

Authors:  Xian-Bin Lin; Lei Jiang; Mao-Hua Ding; Zhen-Hua Chen; Yi Bao; Yi Chen; Wei Sun; Chen-Ran Zhang; Hong-Kang Hu; Zhen Cai; Cheng-Yin Lu; Jue-Yu Zhou; Jun Qian; Xiao-Jun Wu; Wei-Lin Jin; Guo-Han Hu
Journal:  Tumour Biol       Date:  2015-09-26

4.  Clinical significance of NTRK family gene expression in neuroblastomas.

Authors:  Jennifer E Light; Hiroshi Koyama; Jane E Minturn; Ruth Ho; Anisha M Simpson; Radhika Iyer; Jennifer L Mangino; Venkatadri Kolla; Wendy B London; Garrett M Brodeur
Journal:  Pediatr Blood Cancer       Date:  2011-10-11       Impact factor: 3.167

5.  NTRK2 is an oncogene and associated with microRNA-22 regulation in human gastric cancer cell lines.

Authors:  Jinhuai Hu; Yong Huang; Yuanhua Wu; Fengjun Liu; Dong Sun; Kexin Wang; Hui Qu
Journal:  Tumour Biol       Date:  2016-09-23

Review 6.  TRK Inhibition: A New Tumor-Agnostic Treatment Strategy.

Authors:  Shivaani Kummar; Ulrik N Lassen
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

7.  Syntaxin 8 modulates the post-synthetic trafficking of the TrkA receptor and inflammatory pain transmission.

Authors:  Bing Chen; Ling Zhao; Xian Li; Yun-Song Ji; Na Li; Xu-Feng Xu; Zhe-Yu Chen
Journal:  J Biol Chem       Date:  2014-05-28       Impact factor: 5.157

Review 8.  Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer.

Authors:  Hussein Akil; Aurélie Perraud; Marie-Odile Jauberteau; Muriel Mathonnet
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

9.  NTRK2 methylation is related to reduced PTSD risk in two African cohorts of trauma survivors.

Authors:  Vanja Vukojevic; David Coynel; Navid R Ghaffari; Virginie Freytag; Thomas Elbert; Iris-Tatjana Kolassa; Sarah Wilker; James L McGaugh; Andreas Papassotiropoulos; Dominique J-F de Quervain
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-17       Impact factor: 11.205

Review 10.  Trk receptor expression and inhibition in neuroblastomas.

Authors:  Garrett M Brodeur; Jane E Minturn; Ruth Ho; Anisha M Simpson; Radhika Iyer; Carly R Varela; Jennifer E Light; Venkatadri Kolla; Audrey E Evans
Journal:  Clin Cancer Res       Date:  2009-05-05       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.